Kensey Nash Corp (NASDAQ:KNSY)
CAPS Rating:
The Company provides a range of products in the field of resorbable biomaterials and endovascular devices in endovascular and orthopaedic markets.
Growing the love for investing
The Company provides a range of products in the field of resorbable biomaterials and endovascular devices in endovascular and orthopaedic markets.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
The long term growth estimate is 15 and the forward PE is only 11.64. I have a target price of over $36/share.